MALIGNANT PLEURAL MESOTHELIOMA
Clinical trials for MALIGNANT PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Light-activated cancer therapy tested in groundbreaking mesothelioma treatment combo
Disease control CompletedThis study tested whether patients with malignant pleural mesothelioma could complete an intensive combination treatment. The treatment included surgery to remove visible tumors, a special light-activated drug therapy during surgery, followed by chemotherapy and radiation. Resear…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
CRISPR-Edited immune cells battle tough cancers in new trial
Disease control CompletedThis study tested a new type of cell therapy called CTX131 for adults with advanced solid tumors that have returned or stopped responding to standard treatments. CTX131 uses a patient's own immune cells that are genetically modified in a lab to better target and fight cancer cell…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
French doctors track promising new mesothelioma treatment in real patients
Disease control CompletedThis study looked back at medical records of 204 French patients with advanced mesothelioma who couldn't have surgery. Researchers wanted to see how well a two-drug immunotherapy combination worked in real-world settings after it showed promise in earlier trials. They tracked how…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for Tough-to-Treat mesothelioma: targeted chemo shows promise
Disease control CompletedThis study tested whether delivering chemotherapy drugs directly to the tumor through blood vessels could help control advanced pleural mesothelioma. The trial involved 34 adults whose cancer couldn't be removed by surgery and who hadn't responded to standard chemotherapy. Resear…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Radiation blitz before surgery aims to stop deadly cancer spread
Disease control CompletedThis study tested if a short, intense course of radiation to the chest, given just before surgery, could kill cancer cells that might spread during the operation. It involved 104 patients with early-stage malignant pleural mesothelioma, a cancer linked to asbestos exposure. The g…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New hope in fight against deadly asbestos cancer
Disease control CompletedThis study tested whether adding an immunotherapy drug called durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. Pleural mesothelioma is an aggressive cancer often linked to asbestos exposure, with limited treatment options. The trial…
Matched conditions: MALIGNANT PLEURAL MESOTHELIOMA
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC